Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000540739 | SCV000623120 | likely benign | Gorlin syndrome; Medulloblastoma | 2024-01-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV001025517 | SCV001187719 | likely benign | Hereditary cancer-predisposing syndrome | 2018-07-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
ARUP Laboratories, |
RCV003736802 | SCV004562467 | likely benign | not provided | 2023-08-23 | criteria provided, single submitter | clinical testing |